Keywords: alrt, cleared, start, phi/iia, cancer, therapy, allergan

ALRT's Cleared To Start PhI/IIa With Cancer Therapy

Article | 13 January 1997

Print This

- Allergan Ligand Retinoid Therapeutics has been granted clearance bythe US Food and Drug Administration to commence Phase I/IIa trials ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in